Omega Fund Management, LLC
CIK: 0001637359Latest portfolio: $286.5M · Q4 2025
Holdings
11
Total Value
$286.5M
New Positions
0
Closed Positions
1
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | NUVBNuvation Bio | 8,081,089 | $72.4M | 25.27% | -750,000 | |
| 2 | BBOTBridgeBio Oncology Therapeutics Inc. | 3,289,661 | $41.2M | 14.37% | — | |
| 3 | BBNXBeta Bionics Inc. | 1,316,183 | $40.1M | 14.00% | -603,942 | |
| 4 | BCAXBicara Therapeutics Inc. | 2,204,650 | $37.1M | 12.95% | — | |
| 5 | KMTSKestra Med Technologies Ltd | 1,373,591 | $36.4M | 12.71% | -272,302 | |
| 6 | UPBUpstream Bio Inc. | 1,326,293 | $36.0M | 12.57% | -30,000 | |
| 7 | ENGNenGene Holdings Inc. | 876,357 | $7.9M | 2.76% | +350K | |
| 8 | ALMSAlumis Inc. | 653,223 | $6.4M | 2.22% | — | |
| 9 | SANASana Biotechnology, Inc. | 843,750 | $3.4M | 1.20% | — | |
| 10 | IMAImageneBio, Inc. | 455,361 | $3.1M | 1.10% | — | |
| 11 | REPLReplimune Group | 248,672 | $2.4M | 0.84% | — |
Quarterly Changes
New Positions
No new positions this quarter
Closed Positions
- ENGNWCLOSED$63.4M
Sector Breakdown
Healthcare100.0% ($7.240641186401043e+40T)
Filing History
Fund Information
Omega Fund Management, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $286.5M across 11 holdings. The largest position is Nuvation Bio (NUVB), representing 25.3% of the portfolio. Compared to the previous quarter, the fund opened 0 new positions and closed 1 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.